PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Market Access
The African Markets Pharma Can't Ignore
In its new study on pharma market growth in Africa, IMS Health highlights three ‘rising star’ countries from the continent’s sub-Saharan region.
Also posted in Global, healthcare Tagged Africa, Alegeria, Botswana, Egypt, Kenya, Morocco, Nigeria, Pharma, South Africa 3 Comments
Questions About the 2013 Implementation of IPAB
by Tom Norton
With the general election behind us, the anticipated avalanche of ObamaCare regulations has begun. Last week, it was reported that more than 13,000 pages of rules and regulations have been issued by HHS since Nov. 6th. A huge amount of activity, to be sure, but as stated, not surprising. That’s because the law [...]
Also posted in FDA, Legal, Regulatory, healthcare, pricing Tagged Affordable Care Act, CMS, cost-cutting, government, HHS, IPAB, Obamacare, pricing Leave a comment
New Pseudoephedrine Drug Could Hop Back Over the Counter
Yesterday Acura Pharmaceuticals launched its new pseudoephedrine-based product Nexafed, an over-the-counter product aimed at deterring abuse of the illicit drug methamphetamine. Pseudoephedrine, the decongestant known also as the primary ingredient in the production of methamphetamine, has been subject to a federal statute which keeps medicines with the ingredient behind the counter of all pharmacies in [...]
IP Climate Change: Patent Rights Face Headwinds
The pharmaceutical industry as of late has faced a growing movement against patent protection in favor of providing access to low cost medicines, specifically in developing countries.
In Indonesia, the government imposed compulsory licensing on seven drugs used to treat HIV and Hepatitis B in September. In July, China passed a law which grants it power [...]
Also posted in Emerging Markets, IP, Legal, Regulatory, pricing 1 Comment
Pharma Still Doesn't Get Patient Groups